Trigeminal neuralgia (TN) is considered to be one of the most painful afflictions known to medical practice. TN is a disorder of the fifth cranial (trigeminal) nerve. The typical or “classic” form of the disorder (called TN1) causes extreme, sporadic, sudden burning or shock-like facial pain in the areas of the face where the branches of the nerve are distributed – lips, eyes, nose, scalp, forehead, upper jaw, and lower jaw. The “atypical” form of the disorder (called TN2), is characterized by constant aching, burning, stabbing pain of somewhat lower intensity than TN1. A puzzling fact in TGN is that very different treatments yield seemingly similar results in controlling TGN pain. However, closer inspection of the longâterm effects suggests that simple blocks or minimally destructive peripheral procedures lead to transient pain relief, much shorter than seen in more proximal lesions or decompression. Also, following neuroablative procedures, the degree of sensory loss correlates positively with the duration of pain relief. Transcranial magnetic stimulation appears promising, but results are still scarce. Adjunct treatments such as mechanical, electrical, and thermal stimuli sometimes modify pain with fewer adverse effects than medication. Self-adhesive bandages may also be used. Germany people around 666,695 among the total population are suffering from this disease that is 4.38% of the population effected.